John T. Maxwell - Net Worth and Insider Trading

John T. Maxwell Net Worth

The estimated net worth of John T. Maxwell is at least $530,161 dollars as of 2024-12-29. John T. Maxwell is the SVP-CFO of Aquestive Therapeutics Inc and owns about 150,614 shares of Aquestive Therapeutics Inc (AQST) stock worth over $530,161. Details can be seen in John T. Maxwell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John T. Maxwell has not made any transactions after 2020-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John T. Maxwell

To

John T. Maxwell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John T. Maxwell owns 2 companies in total, including Aquestive Therapeutics Inc (AQST) , and Wejo Group Ltd (WEJOF) .

Click here to see the complete history of John T. Maxwell’s form 4 insider trades.

Insider Ownership Summary of John T. Maxwell

Ticker Comapny Transaction Date Type of Owner
AQST Aquestive Therapeutics Inc 2020-08-18 SVP-Chief Financial Officer
WEJOF Wejo Group Ltd 2021-11-19 director & Chief Financial Officer

John T. Maxwell Latest Holdings Summary

John T. Maxwell currently owns a total of 1 stock. John T. Maxwell owns 150,614 shares of Aquestive Therapeutics Inc (AQST) as of August 18, 2020, with a value of $530,161.

Latest Holdings of John T. Maxwell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AQST Aquestive Therapeutics Inc 2020-08-18 150,614 3.52 530,161

Holding Weightings of John T. Maxwell


John T. Maxwell Form 4 Trading Tracker

According to the SEC Form 4 filings, John T. Maxwell has made a total of 1 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aquestive Therapeutics Inc is the sale of 3,000 shares on August 18, 2020, which brought John T. Maxwell around $24,000.

Insider Trading History of John T. Maxwell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John T. Maxwell Trading Performance

GuruFocus tracks the stock performance after each of John T. Maxwell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John T. Maxwell is -29.07%. GuruFocus also compares John T. Maxwell's trading performance to market benchmark return within the same time period. The performance of stocks bought by John T. Maxwell within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John T. Maxwell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John T. Maxwell

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -22.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -15.23 LIMIT LIMIT LIMIT LIMIT LIMIT

John T. Maxwell Ownership Network

Ownership Network List of John T. Maxwell

No Data

Ownership Network Relation of John T. Maxwell

Insider Network Chart

John T. Maxwell Owned Company Details

What does Aquestive Therapeutics Inc do?

Who are the key executives at Aquestive Therapeutics Inc?

John T. Maxwell is the SVP-Chief Financial Officer of Aquestive Therapeutics Inc. Other key executives at Aquestive Therapeutics Inc include SVP & Operations Cassie Jung , director & Chief Innovation/Tech Officer Alexander Mark Schobel , and Chief Medical Officer Carl N Kraus .

Aquestive Therapeutics Inc (AQST) Insider Trades Summary

Over the past 18 months, John T. Maxwell made no insider transaction in Aquestive Therapeutics Inc (AQST). Other recent insider transactions involving Aquestive Therapeutics Inc (AQST) include a net sale of 75,000 shares made by Alexander Mark Schobel , and a net sale of 44 shares made by Cassie Jung .

In summary, during the past 3 months, insiders sold 44 shares of Aquestive Therapeutics Inc (AQST) in total and bought 0 shares, with a net sale of 44 shares. During the past 18 months, 75,044 shares of Aquestive Therapeutics Inc (AQST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 75,044 shares.

Aquestive Therapeutics Inc (AQST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aquestive Therapeutics Inc Insider Transactions

No Available Data

John T. Maxwell Mailing Address

Above is the net worth, insider trading, and ownership report for John T. Maxwell. You might contact John T. Maxwell via mailing address: 30 Technology Drive, Warren Nj 07059.

Discussions on John T. Maxwell

No discussions yet.